Currently, the clinical treatment of DKD mainly includes angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), and sodium-dependent glucose transporter 2 (SGLT2) inhibitors [26,27]. Here, ACE is linked to diabetic kidney disease.